GC

GC collaborates with I.P. ONE to launch the "Vixol: Transformative Innovation for Sustainable World" campaign, marking the first time in Thailand of recycled colored plastic bottles.

Retrieved on: 
星期四, 十二月 21, 2023

This initiative involves transforming discarded colored plastic household waste into recyclable bottles, piloting it with the "VIXOL POWER black bottle," creating a closed loop system for sustainable plastic packaging production.

Key Points: 
  • This initiative involves transforming discarded colored plastic household waste into recyclable bottles, piloting it with the "VIXOL POWER black bottle," creating a closed loop system for sustainable plastic packaging production.
  • One is recognized as a producer and distributor of Thai consumer goods under popular brands such as Hygiene, Vixol, Ivy, Dance, and Focus.
  • One has conducted its business operations that is aligned with sustainability, considering the value of resources and the environment.
  • This endeavor aims to enhance the sustainability of recycling practices in Thailand and develop alternative material bottle packaging, such as paper-based solutions."

GC collaborates with I.P. ONE to launch the "Vixol: Transformative Innovation for Sustainable World" campaign, marking the first time in Thailand of recycled colored plastic bottles.

Retrieved on: 
星期四, 十二月 21, 2023

This initiative involves transforming discarded colored plastic household waste into recyclable bottles, piloting it with the "VIXOL POWER black bottle," creating a closed loop system for sustainable plastic packaging production.

Key Points: 
  • This initiative involves transforming discarded colored plastic household waste into recyclable bottles, piloting it with the "VIXOL POWER black bottle," creating a closed loop system for sustainable plastic packaging production.
  • One is recognized as a producer and distributor of Thai consumer goods under popular brands such as Hygiene, Vixol, Ivy, Dance, and Focus.
  • One has conducted its business operations that is aligned with sustainability, considering the value of resources and the environment.
  • This endeavor aims to enhance the sustainability of recycling practices in Thailand and develop alternative material bottle packaging, such as paper-based solutions."

GC Collaborates with MHI to explore the utilization of hydrogen, ammonia and CCS technology to develop a large-scale petrochemical plant to achieve Net Zero

Retrieved on: 
星期二, 十二月 19, 2023

Ltd. (MHI-AP) to jointly study the technologies required to develop a large-scale petrochemical complex that aims to support Thailand's Carbon Neutrality by 2050.

Key Points: 
  • Ltd. (MHI-AP) to jointly study the technologies required to develop a large-scale petrochemical complex that aims to support Thailand's Carbon Neutrality by 2050.
  • MHI-AP will support this through providing carbon capture technologies as well as hydrogen combustion gas turbines and ammonia gas turbines.
  • One of the initiatives to reduce greenhouse gas emissions responsibly involves researching ways to improve and develop processes by integrating modern technologies.
  • For instance, hydrogen/ammonia can be incorporated as fuel in power generation instead of natural gas to achieve net-zero greenhouse gas emissions.

GC Collaborates with MHI to explore the utilization of hydrogen, ammonia and CCS technology to develop a large-scale petrochemical plant to achieve Net Zero

Retrieved on: 
星期二, 十二月 19, 2023

Ltd. (MHI-AP) to jointly study the technologies required to develop a large-scale petrochemical complex that aims to support Thailand's Carbon Neutrality by 2050.

Key Points: 
  • Ltd. (MHI-AP) to jointly study the technologies required to develop a large-scale petrochemical complex that aims to support Thailand's Carbon Neutrality by 2050.
  • MHI-AP will support this through providing carbon capture technologies as well as hydrogen combustion gas turbines and ammonia gas turbines.
  • One of the initiatives to reduce greenhouse gas emissions responsibly involves researching ways to improve and develop processes by integrating modern technologies.
  • For instance, hydrogen/ammonia can be incorporated as fuel in power generation instead of natural gas to achieve net-zero greenhouse gas emissions.

The Granular Certificate Trading Alliance, Led by LevelTen Energy and in Collaboration with AES, Constellation, Google, and Microsoft, Forms to Build a Critical Solution, with ICE, to Decarbonize the Grid

Retrieved on: 
星期四, 十二月 14, 2023

As the solution scales, it will accelerate the energy transition by helping to decarbonize electric grids.

Key Points: 
  • As the solution scales, it will accelerate the energy transition by helping to decarbonize electric grids.
  • View the full release here: https://www.businesswire.com/news/home/20231214579198/en/
    Corporate clean energy procurements have skyrocketed over the past 10 years, making annual commitments to match consumption with 100% renewable energy commonplace.
  • However, annual EACs come with an inherent challenge: incentivizing carbon-free energy production during dark or windless hours in the absence of an hourly market signal.
  • LevelTen Energy: “The GC Trading Alliance is tackling the next challenge for the energy transition, which is driving carbon-emitting resources off the grid at all hours.

Cerno Bioscience GC/MS Software Accelerates Unknown Compound Identification

Retrieved on: 
星期三, 十二月 13, 2023

This software release is a significant technological advancement for GC/MS unknown identification and semi-quantification, offering a powerful market-first solution.

Key Points: 
  • This software release is a significant technological advancement for GC/MS unknown identification and semi-quantification, offering a powerful market-first solution.
  • GC/ID is a vendor-neutral software application that accelerates the unknown ID workflow and dramatically improves the confidence of results.
  • This provides for more accurate and confident unknown identification over solutions relying solely on Library Search scores.
  • For more information on GC/ID, please contact Cerno Bioscience at [email protected] , call +1 203-312-1150, or visit www.cernobioscience.com

Seismic Therapeutic Closes $121 Million Series B Financing to Advance Immunology Pipeline Optimized by its Machine Learning Platform

Retrieved on: 
星期一, 十二月 4, 2023

Seismic Therapeutic, Inc ., the machine learning immunology company, today announced that it has closed a $121 million Series B financing.

Key Points: 
  • Seismic Therapeutic, Inc ., the machine learning immunology company, today announced that it has closed a $121 million Series B financing.
  • In addition, the Series B will enable the continued growth of the company’s pipeline in both the IgSc and DcB product areas, beyond the lead programs.
  • This progress resulted from Seismic’s integration of leading-edge machine learning into drug development in a specific area – biologics for immunology – powered by a diverse team of drug developers and machine learning innovators.
  • “This financing enables us to continue our momentum and advance both of our exciting lead programs into the clinic.

NatureWorks Appoints Erik Ripple as New President and CEO

Retrieved on: 
星期二, 十一月 28, 2023

Today NatureWorks , a leading manufacturer of polylactic acid (PLA) biopolymers made from renewable resources, announced the appointment of Erik Ripple as the company’s new President and Chief Executive Officer.

Key Points: 
  • Today NatureWorks , a leading manufacturer of polylactic acid (PLA) biopolymers made from renewable resources, announced the appointment of Erik Ripple as the company’s new President and Chief Executive Officer.
  • Ripple will succeed interim President and CEO, Jill Zullo, who has served in the role since March 2023 when former CEO, Rich Altice, retired from NatureWorks.
  • Ripple was previously the President of Asia Pacific, and the Senior Vice President for Performance Materials (PM) while living in Shanghai, China.
  • “We are pleased to welcome Erik as the new CEO of NatureWorks.

GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

Retrieved on: 
星期一, 十二月 18, 2023

The ALYGLO pivotal phase 3 clinical study followed FDA guidance for the treatment of patients with PI.

Key Points: 
  • The ALYGLO pivotal phase 3 clinical study followed FDA guidance for the treatment of patients with PI.
  • ­­The results of the phase 3 trial by GC Biopharma are published in Frontiers in Immunology (2021).
  • Dr. Eun-chul Huh, President and CEO of GC Biopharma, said, "The approval of ALYGLO by the US FDA is a significant milestone for GC Biopharma and patients with primary immunodeficiency disease.
  • For any medical or scientific questions regarding ALYGLO, call the GC Biopharma USA medical department at 1-833-426-6426, or email [email protected] .

GC has achieved the top position in the Chemicals Sector according to the DJSI World Index, securing the highest score for five consecutive years. It stands as a global sustainability leadership.

Retrieved on: 
星期五, 十二月 15, 2023

GC operates globally in the Chemicals Sector and has devised strategies to transition into a low-carbon or net-zero company by 2050.

Key Points: 
  • GC operates globally in the Chemicals Sector and has devised strategies to transition into a low-carbon or net-zero company by 2050.
  • These includes:
    Increasing the proportion of renewable energy usage, integrating technologies and digitalization systems into manufacturing processes.
  • Carbon reduction through carbon sequestration from nature-based solutions via the "The more we plant, the better it gets" project.
  • Acknowledging the importance of natural resources, conducting business operations by considering the impacts on biodiversity in all operational areas.